fundmomentum.vc

Autism Impact Fund II

United States
Seed
Share

About Autism Impact Fund II

Autism Impact Fund II invests in seed and Series A companies building AI-enabled solutions for behavioral health, autism care, and complex chronic conditions. Based in New York with offices in San Francisco, Winter Park, and Nashville.

Investment Focus

Location / RegionUnited States
Funding StageSeed
Industry Focus
Ai Ml
Digital Health
Therapeutics

Investor Signals Profile

active

Sweet Spot

Tech-enabled behavioral health founder targeting payer-aligned, outcomes-driven neurodiversity care solutions

neurodiversity
behavioral-health-tech
AI-enabled-care
value-based-care
precision-medicine
diagnostics-to-treatment
outcomes-based-care
accessible-affordable-care

Bullish Signals

Fund II first close achieved April 2026 with $150M total AUMblog
Fund I exits validated model: Joshin and Spectrum AI successfully acquiredblog
Thesis expanding to trillion-dollar-plus neurodiversity and behavioral health marketblog
Active portfolio spans Seed to Series C across 15+ companieswebsite
Imagine Pediatrics raises $67M; AIF ecosystem scalingwebsite
Yahoo Finance: AIF autism investments attracting investor noticewebsite
Portfolio active from Seed 2021 through Series B 2025website
Covers blood-test dx, microbiome, precision nutrition, special ed techwebsite
Hosted Autism & Behavioral Health Investment Roundtable Webinarwebsite
New 2025 deals: special ed, caregiver tech, 24/7 care accesswebsite
Deployment spans Seed through Series D; multi-stage activewebsite
2024–2025 momentum: 4 new Series A, 2 Growth, 2 Strategic dealswebsite
Portfolio breadth: diagnostics, therapeutics, caregiver enablement, employmentwebsite
Series D 2026: comprehensive primary care available wherever you arewebsite
Payer-agnostic accessibility mission: care regardless of insurerwebsite
Zero-wait-time ASD diagnosis and clinically-validated data-driven therapy focuswebsite

Contrarian Signals

Fee-for-service models without value-based care path are explicit non-fitblog
Behavioral health reimbursement risk: politically sensitive, uneven state adoptionblog
Portfolio density in 2021 vintages; newer deals still maturingwebsite
Heavy 2021 cohort; portfolio concentration risk evidentwebsite

Founder Do's

Show clear alignment with value-based care and payer outcomes measurement
Demonstrate AI or data infrastructure connecting diagnosis to personalized treatment
Address co-occurring conditions like ADHD, dyslexia, or anxiety alongside autism
Show a path to measurable cost reduction for payers and health systems
Cover diagnostics, therapeutics, special ed tech, caregiver enablement, or 24/7 access
Build toward universal access regardless of insurer or geography

Founder Don'ts

Pitch a pure fee-for-service ABA therapy model with no value-based care path
Position AI as standalone product without data infrastructure backbone
Ignore reimbursement alignment or payer strategy in your pitch

Key GPs & Partners

CM
Christopher Male
Founder & Co-Managing Partner
mission-driventhesis-drivenex-operator

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund SizeUSD
Saves0
Website
LinkedIn

Key People

Chris Male, Robert Sarrazin

Christopher MaleFounder & Co-Managing Partner

Related Funds

Rittenhouse Ventures Fund III

$75M
United States
Pre Seed
Ai Ml, Saas
Fund Manager:Saul Richter, David Nevas, Sushma Rajagopalan
Pre Seed
Ai Ml
Saas

321Catalyst (Mitsui Chemicals Fund II)

$60M
United States
Seed
Ai Ml, Climate Sustainability, Mobility Transport
Fund Manager:Shunsuke Fujii
Seed
Ai Ml
Climate Sustainability
Mobility Transport

South Park Commons Fund IV

$5.8B
United States
Seed
Seed